Detalhe da pesquisa
1.
PET Imaging of Peptide Probe Al[18F]F-NOTA-PCP1 for Monitoring the Engagement of PD-L1 Antibodies in Tumors.
Mol Pharm
; 21(3): 1515-1525, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291578
2.
Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade.
Gut
; 71(3): 521-533, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33685966
3.
Correction to "PET Imaging of Peptide Probe Al[18F]F-NOTA-PCP1 for Monitoring the Engagement of PD-L1 Antibodies in Tumors".
Mol Pharm
; 21(5): 2622, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530951
4.
Evaluation of specific RBE in different cells of hippocampus under high-dose proton irradiation in rats.
Sci Rep
; 14(1): 8193, 2024 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589544
5.
The current advances and future directions of PD-1/PD-L1 blockade in head and neck squamous cell carcinoma (HNSCC) in the era of immunotherapy.
Int Immunopharmacol
; 120: 110329, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207445
6.
The Efficacy of Pretreatment 18F-FDG PET-CT-Based Deep Learning Network Structure to Predict Survival in Nasopharyngeal Carcinoma.
Clin Med Insights Oncol
; 17: 11795549231171793, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37251551
7.
YTHDF2 inhibition potentiates radiotherapy antitumor efficacy.
Cancer Cell
; 41(7): 1294-1308.e8, 2023 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37236197
8.
Epitranscriptional regulation of TGF-ß pseudoreceptor BAMBI by m6A/YTHDF2 drives extrinsic radioresistance.
J Clin Invest
; 133(24)2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38099498
9.
Determining optimal clinical target volume margins in high-grade glioma based on microscopic tumor extension and magnetic resonance imaging.
Radiat Oncol
; 16(1): 97, 2021 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34098965
10.
All-trans retinoic acid overcomes solid tumor radioresistance by inducing inflammatory macrophages.
Sci Immunol
; 6(60)2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34723044
11.
The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia.
J Hematol Oncol
; 14(1): 92, 2021 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34118979
12.
PD-L1 in Combination with CD8+TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell Carcinoma.
Cancer Manag Res
; 12: 13233-13239, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33380831
13.
The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes.
Front Immunol
; 11: 580335, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33224142
14.
In vitro and in vivo evaluation of the safety and efficacy of a novel liquid fiducial marker for image-guided radiotherapy.
Oncol Lett
; 20(1): 569-580, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32565982
15.
Plasma levels of soluble programmed death ligand 1 (sPD-L1) in WHO II/III nasopharyngeal carcinoma (NPC): A preliminary study.
Medicine (Baltimore)
; 98(39): e17231, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31574833
16.
Ten-Year Outcomes Of Intensity-Modulated Radiotherapy (IMRT) Combine With Chemotherapy Versus IMRT Alone For Stage II Nasopharyngeal Carcinoma In The Real-World Study (RWD).
Cancer Manag Res
; 11: 8893-8903, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31632149
17.
Genetic characterization drives personalized therapy for early-stage non-small-cell lung cancer (NSCLC) patients and survivors with metachronous second primary tumor (MST): A case report.
Medicine (Baltimore)
; 96(10): e6221, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28272214
18.
Consolidative thoracic radiotherapy for extensive stage small cell lung cancer.
Oncotarget
; 8(13): 22251-22261, 2017 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28118612